Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sartorius AG (DE:SRT3)
XETRA:SRT3
Sartorius (SRT3) Stock Price & Analysis
21 Followers
SRT3 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€199.50 - €382.93
Previous Close€220.9
Volume30.84K
Average Volume (3M)116.84K
Market Cap
€13.33B
Enterprise Value€16.34B
Total Cash (Recent Filing)€196.80M
Total Debt (Recent Filing)€2.54B
Price to Earnings (P/E)101.6
Beta1.67
Next Earnings
Jul 19, 2024EPS Estimate
€0.97Last Dividend Ex-Date
Apr 02, 2024Dividend Yield0.35%
Share Statistics
EPS (TTM)2.17
Shares Outstanding37,440,000
10 Day Avg. Volume129,090
30 Day Avg. Volume116,845
Standard Deviation0.12
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€311.50Price Target Upside38.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Sartorius News
PremiumPre-Earnings
Is 0NIR a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Cost ControlAnnounced €100m 2024 and €130m 2025 cost cuts make a clear positive impact.
Financial PerformanceSigns of improvement in end markets, solid cost control efforts, and easing comparables are reasons for optimism.
Order IntakeBPS order intake was up 15% year-over-year, and North America dramatically improved by 26.1%, indicating recovery.
Bears Say
Market SentimentInvestors may be inclined to see SRT as less investable today with a likely rocky recovery ahead.
Order BookNear-term signals of sequential order book deterioration over 2Q and a perceived reduction in visibility on end market customers.
RevenueTopline revenue was a miss compared to forecasts, driven by continued weaker order flows.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
17.39% Mutual Funds
10.65% Other Institutional Investors
71.96% Public Companies and
Individual Investors
SRT3 FAQ
What was Sartorius AG’s price range in the past 12 months?
Sartorius AG lowest stock price was €199.50 and its highest was €382.93 in the past 12 months.
What is Sartorius AG’s market cap?
Currently, no data Available
When is Sartorius AG’s upcoming earnings report date?
Sartorius AG’s upcoming earnings report date is Jul 19, 2024 which is in 14 days.
How were Sartorius AG’s earnings last quarter?
Sartorius AG released its earnings results on Apr 18, 2024. The company reported €1.01 earnings per share for the quarter, missing the consensus estimate of €1.102 by -€0.092.
Is Sartorius AG overvalued?
According to Wall Street analysts Sartorius AG’s price is currently Undervalued.
Does Sartorius AG pay dividends?
Sartorius AG pays a Annually dividend of €0.74 which represents an annual dividend yield of 0.35%. See more information on Sartorius AG dividends here
What is Sartorius AG’s EPS estimate?
Sartorius AG’s EPS estimate is €0.97.
How many shares outstanding does Sartorius AG have?
Sartorius AG has 37,440,000 shares outstanding.
What happened to Sartorius AG’s price movement after its last earnings report?
Sartorius AG reported an EPS of €1.01 in its last earnings report, missing expectations of €1.102. Following the earnings report the stock price went down -15.408%.
Which hedge fund is a major shareholder of Sartorius AG?
Currently, no hedge funds are holding shares in DE:SRT3
---
Sartorius Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€311.50 (38.08% Upside)
€311.50 (38.08% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.24%
12-Months-Change
Fundamentals
Return on Equity
6.47%
Trailing 12-Months
Asset Growth
52.60%
Trailing 12-Months
Company Description
Sartorius AG
Sartorius AG is the leading provider of biopharmaceutical fermentation and fluid management. In 2019, the bioprocess division contributed 77% to total revenue and the lab division the remaining 23%. The bioprocess division is traded as a separate company, Sartorius Stedim Biotech. Sartorius AG has a 74% ownership of this subsidiary with 85% voting control. In addition to biomanufacturing equipment and consumables, Sartorius offers a wide range of products for general lab use, such as scales, pipettes, and filtration equipment. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (38% of 2019 sales), the Americas (37%), and Asia-Pacific (25%). Sartorius employs over 9,000 people and has operations in more than 30 countries.
---
SRT3 Stock 12 Month Forecast
Average Price Target
€311.50
▲(38.08% Upside)
Technical Analysis
Best Analysts Covering SRT3
1 Year
1 Year Success Rate
11/34 ratings generated profit
1 Year Average Return
+2.54%
reiterated a buy rating 4 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 32.35% of your transactions generating a profit, with an average return of +2.54% per trade.
---